Minervini Andrea, Campi Riccardo, Sessa Francesco, Derweesh Ithaar, Kaouk Jihad H, Mari Andrea, Rha Koon H, Sessa Maurizio, Volpe Alessandro, Carini Marco, Uzzo Robert G
Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.
Department of Urology, Careggi Hospital, University of Florence, Florence, Italy -
Minerva Urol Nefrol. 2017 Dec;69(6):523-538. doi: 10.23736/S0393-2249.17.02864-8. Epub 2017 Jan 26.
The definition of the safest width of healthy renal margin to achieve oncological efficacy and therefore of the safest resection technique (RT) during partial nephrectomy (PN) continues to be widely debated. The aim of this study is to evaluate the prevalence of positive surgical margins (PSM), loco-regional recurrence (LRR) and renal recurrence (RER) rates after simple enucleation (SE) and standard partial nephrectomy (SPN) for malignant renal tumors.
A systematic review of the English-language literature was performed through August 2016 using the Medline, Web of Science and Embase databases according to the PRISMA criteria. A systematic review and meta-analysis was performed in those studies that defined the exact anatomical location of recurrence after PN.
Overall, 33 studies involving 11,282 patients were selected for quantitative analysis. At a median follow-up of 43 (SE) and 52 (SPN) months, the pooled estimates of the prevalence of PSMs, LRR and RER were 2.7% (95% CI: 1.5-4.6%, P<0.001) and 0.4% (95% CI: 0.1-2.2%, P=0.018), 2.0% (95% CI: 1.4-2.8%, P<0.001) and 0.9% (95% CI: 0.5-1,7%, P=0.04), 1.5% (95% CI: 0.9-2.3%, P=0.001) and 0.9% (95% CI: 0.5-1,7%, P=0.40) in patients undergoing SPN and SE, respectively.
Our systematic analysis and meta-analysis demonstrates that SE is noninferior to SPN regarding PSM, LRR and RER rates in patients undergoing PN for malignant renal tumors. Further studies using standardized reporting tools are needed to evaluate the role of resection techniques for oncologic outcomes after PN.
为实现肿瘤学疗效,健康肾切缘的最安全宽度定义以及因此在部分肾切除术(PN)期间的最安全切除技术(RT)仍存在广泛争议。本研究的目的是评估对于恶性肾肿瘤,单纯剜除术(SE)和标准部分肾切除术(SPN)后手术切缘阳性(PSM)、局部区域复发(LRR)和肾复发(RER)率的发生率。
根据PRISMA标准,通过使用Medline、科学网和Embase数据库,对截至2016年8月的英文文献进行了系统评价。对那些定义了PN后复发的确切解剖位置的研究进行了系统评价和荟萃分析。
总体而言,选择了33项涉及11282例患者的研究进行定量分析。在中位随访43个月(SE组)和52个月(SPN组)时,PSM、LRR和RER发生率的汇总估计值在接受SPN和SE的患者中分别为2.7%(95%CI:1.5 - 4.6%,P<0.001)和0.4%(95%CI:0.1 - 2.2%,P = 0.018)、2.0%(95%CI:1.4 - 2.8%,P<0.001)和0.9%(95%CI:0.5 - 1.7%,P = 0.04)、1.5%(95%CI:0.9 - 2.3%,P = 0.001)和0.9%(95%CI:0.5 - 1.7%,P = 0.40)。
我们的系统分析和荟萃分析表明,对于接受PN治疗恶性肾肿瘤的患者,在PSM、LRR和RER率方面,SE不劣于SPN。需要使用标准化报告工具进行进一步研究,以评估切除技术对PN后肿瘤学结局的作用。